Suchergebnisse - "Sanz, Miguel A"

PubPharm (15)

1

Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients

enthalten in: Leukemia & lymphoma | 2021

von Boluda, B. | Martínez-Cuadrón, D. | Algarra, L. | +21

2

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

enthalten in: Cancer | 2021

von Vives, S. | Martínez-Cuadrón, D. | Bergua Burgues, J. | +31

3

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +19

ErratumIn: Ann Hematol. 2018 Feb 23;:. - PMID 29473097

4

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

enthalten in: The New England journal of medicine | 2017

von Stone, R. | Mandrekar, S. | Sanford, B. | +26

CommentIn: N Engl J Med. ;377(19):1901. - PMID 29120132

5

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

enthalten in: Pharmacogenetics and genomics | 2017

von Megías-Vericat, J. | Montesinos, P. | Herrero, M. | +6

6

A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia

enthalten in: British journal of haematology | 2016

von Bergua, J. | Montesinos, P. | Martinez-Cuadrón, D. | +18

7

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

8

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

9

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

10

Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia

enthalten in: Annals of hematology | 2014

von Martínez-Cuadrón, D. | Montesinos, P. | Oriol, A. | +10